Antiretroviral medication treatment for all HIV-infected individuals: a protocol using innovative multilevel methodologies to evaluate New York City's universal ART policy among problem substance users

被引:5
作者
Campbell, Aimee N. C. [1 ]
Des Jarlais, Don [2 ]
Hannah, Cooper [3 ]
Braunstein, Sarah [4 ]
Tross, Susan [1 ,5 ]
Kersanske, Laura [4 ]
Borges, Christine [4 ]
Pavlicova, Martina [6 ]
Jefferson, Kevin [3 ]
Newville, Howard [5 ]
Weaver, Laurel [5 ]
Wolff, Margaret [5 ]
机构
[1] Columbia Univ, Med Ctr, Dept Psychiat, New York State Psychiat Inst, 1051 Riverside Dr,Box 120, New York, NY 10032 USA
[2] Icahn Sch Med Mt Sinai, 39 Broadway,5th Floor, New York, NY 10006 USA
[3] Emory Univ, Rollins Sch Publ Hlth, Dept Behav Sci & Hlth Educ, 1518 Clifton Rd NE,Room 568, Atlanta, GA 30322 USA
[4] New York City Dept Hlth & Mental Hyg, 42-09 28th St, Long Isl City, NY 11101 USA
[5] Mt Sinai St Lukes Hosp, Dept Psychiat & Behav Hlth, 1111 Amsterdam Ave,11th Floor, New York, NY 10025 USA
[6] Columbia Univ, Mailman Sch Publ Hlth, Dept Biostat, 722 West 168th St,6th Floor,637, New York, NY 10032 USA
基金
美国国家卫生研究院;
关键词
HIV/AIDS; Adherence; Antiretroviral therapy; Substance use; Affordable care act; SEXUALLY-TRANSMITTED-DISEASES; INJECTION-RELATED INFECTIONS; SELF-REPORTED ADHERENCE; RISK-FACTORS; DRUG-USERS; VIRAL SUPPRESSION; CLINICAL-OUTCOMES; THERAPY ADHERENCE; SPATIAL ACCESS; COCAINE USE;
D O I
10.1186/s12913-016-1554-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background: The intersection of HIV-related health outcomes and problem substance use has been well documented. New York City continues to be a focal point of the U.S. HIV epidemic. In 2011, the NYC Department of Health and Mental Hygiene (NYC DOHMH) issued a recommendation that all HIV infected individuals should be offered antiretroviral therapy (ART) regardless of CD4 cell count or other indicators of disease progression. This policy is based in the concept of "treatment as prevention," in which providing ART to people living with HIV (PLWH) greatly reduces the likelihood of HIV transmission, while also improving individual health. The " ART for ALL" (AFA) study was designed to inform modifications to and identify gaps in the implementation of universal ART, and specifically to help guide allocation of resources to obtain local policy goals for increasing viral suppression among PLWH who have problem substance use. Methods/Design: The AFA Study is informed by two complementary frameworks: Glasgow and colleagues' RE-AIM model, a multi-level framework developed to guide the evaluation of implementation of new policies, and Bronfrenbrenner's ecological systems model, which conceptualizes the bi-directional interplay between people and their environment. Using multi-level data and mixed methods, the primary aims of the AFA Study are to assess rates of viral load suppression, using the NYC HIV Surveillance Registry, within 12 months of HIV diagnosis with (a) yearly cohorts of high-risk-to-transmit, difficult-to-treat, substance using patients recruited from NYC Sexually Transmitted Disease clinics and a large detoxification unit and (b) yearly cohorts of all newly HIV diagnosed people in NYC. Further goals include (c) recruiting cross-sectional samples of HIV/AIDS service providers to assess ART initiation with problem substance users and d) examining geographic factors that influence rates of viral load suppression. An Implementation Collaborative Board meets regularly to guide study procedures and interpret results. Discussion: The AFA Study has the unique strength of accessing and analyzing data at multiple levels using mixed methodology, taking advantage of NYC DOHMH biomedical surveillance data. If successful, others may benefit from lessons learned to inform local and state policies to improve the health of PLWH and further reduce HIV transmission.
引用
收藏
页数:13
相关论文
共 102 条
[1]   Substance use, need, and demand for substance user treatment services in patients treated for sexually transmitted diseases in Michigan [J].
Aktan, GB ;
Calkins, RF ;
Johnson, DR .
SUBSTANCE USE & MISUSE, 2001, 36 (12) :1651-1676
[2]  
[Anonymous], CROI 2013 P 20 C RET
[3]  
[Anonymous], 2012 DELSTAT
[4]  
[Anonymous], ANN BEHAV SCI MED ED
[5]  
[Anonymous], LAWS 2010 HIV MAND R
[6]  
[Anonymous], 2010 DELSTAT
[7]  
[Anonymous], 2012 US CENS BUR ZIP
[8]  
[Anonymous], 2007 2011 AM COMM SU
[9]  
[Anonymous], 2011 US CENS BUR ZIP
[10]  
[Anonymous], 2014, J AIDS HIV RES